Why do we need new therapies for patients with HFrEF?
Topic:
Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker:
Professor B. Merkely (Budapest, HU)
Sponsored by Charité Berlin
Event:
Heart Failure 2018
Congress Presentation
About the speaker
Professor Bela Merkely
Semmelweis University Heart and Vascular Center, Budapest (Hungary)
14
presentations
3
followers
3 more presentations in this session
Welcome and introduction - Baroreflex activation therapy in Heart Failure with reduced Ejection Fraction (HFrEF): overcoming the limits of currently available therapies.
Speaker: Professor S. Anker (Berlin, DE) Professor G. Filippatos (Athens, GR)
Review of new approaches to the management of HFrEF.
Speaker: Doctor E. Gronda (Sesto S. Giovanni, IT)
The developing case for using baroreflex activation therapy in HFrEF.
Speaker: Professor J. Bauersachs (Hannover, DE)
Access the full session
Baroreflex activation therapy in Heart Failure with reduced Ejection Fraction (HFrEF): overcoming the limits of currently available therapies
Speakers:
Professor B. Merkely, Professor S. Anker, Professor G. Filippatos, Doctor E. Gronda, Professor J. Bauersachs
About the event
ESC 365 is supported by
